XML 29 R21.htm IDEA: XBRL DOCUMENT v3.22.1
Segment Information and Concentrations (Tables)
9 Months Ended
Mar. 31, 2022
3 Segment Information  
Segment information

 

 

Benchtop Laboratory Equipment

 

 

Bioprocessing Systems

 

 

Corporate And Other

 

 

Consolidated

 

Three Months Ended March 31, 2022:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$2,434,600

 

 

$430,300

 

 

$-

 

 

$2,864,900

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign Sales

 

 

783,600

 

 

 

269,700

 

 

 

-

 

 

 

1,053,300

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (Loss) From Operations

 

 

247,300

 

 

 

(1,651,700)

 

 

(337,900)

 

 

(1,742,300)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets

 

 

10,231,100

 

 

 

10,024,261

 

 

 

10,271,439

 

 

 

30,526,800

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long-Lived Asset Expenditures

 

 

16,500

 

 

 

158,000

 

 

 

-

 

 

 

174,500

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and Amortization

 

 

24,600

 

 

 

229,900

 

 

 

-

 

 

 

254,500

 

 

Benchtop Laboratory Equipment

 

 

Bioprocessing Systems

 

 

Corporate And Other

 

 

Consolidated

 

Three Months Ended March 31, 2021:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$2,365,700

 

 

$142,900

 

 

$-

 

 

$2,508,600

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign Sales

 

 

942,200

 

 

 

102,600

 

 

 

-

 

 

 

1,044,800

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (Loss) From Operations

 

 

394,700

 

 

 

(1,323,900)

 

 

(929,600)

 

 

(1,858,800)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets

 

 

5,979,400

 

 

 

1,281,200

 

 

 

6,639,700

 

 

 

13,900,300

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long-Lived Asset Expenditures

 

 

18,600

 

 

 

92,100

 

 

 

-

 

 

 

110,700

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and Amortization

 

 

30,000

 

 

 

16,700

 

 

 

-

 

 

 

46,700

 

 

 

Benchtop Laboratory Equipment

 

 

Bioprocessing Systems

 

 

Corporate And Other

 

 

Consolidated

 

Nine Months Ended March 31, 2022:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$7,465,700

 

 

$1,157,800

 

 

$-

 

 

$8,623,500

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign Sales

 

 

2,814,700

 

 

 

791,200

 

 

 

-

 

 

 

3,605,900

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (Loss) From Operations

 

 

1,107,000

 

 

 

(5,091,300)

 

 

(1,127,200)

 

 

(5,111,500)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets

 

 

10,231,100

 

 

 

10,024,261

 

 

 

10,271,439

 

 

 

30,526,800

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long-Lived Asset Expenditures

 

 

83,100

 

 

 

321,300

 

 

 

-

 

 

 

404,400

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and Amortization

 

 

71,200

 

 

 

510,600

 

 

 

-

 

 

 

581,800

 

 

Benchtop Laboratory Equipment

 

 

Bioprocessing Systems

 

 

Corporate And Other

 

 

Consolidated

 

Nine Months Ended March 31, 2021:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$6,803,300

 

 

$441,800

 

 

$-

 

 

$7,245,100

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign Sales

 

 

2,724,800

 

 

 

395,000

 

 

 

-

 

 

 

3,119,800

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (Loss) From Operations

 

 

1,347,100

 

 

 

(2,598,000)

 

 

(1,048,000)

 

 

(2,298,900)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets

 

 

5,979,400

 

 

 

1,281,200

 

 

 

6,639,700

 

 

 

13,900,300

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long-Lived Asset Expenditures

 

 

54,100

 

 

 

170,800

 

 

 

-

 

 

 

224,900

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and Amortization

 

 

79,700

 

 

 

46,500

 

 

 

500

 

 

 

126,700